
COHANCECohance Lifesciences Ltd.
Cohance Lifesciences Q2 FY27 Results: Consolidated Net Profit ₹2.27 Crore on Total Income of ₹489 Crore
Cohance Lifesciences (NSE: COHANCE) reported consolidated total income of ₹489.06 crore and consolidated net profit of ₹2.27 crore for the quarter ended 30 Sep 2026, it said in a filing on 06 Nov 2026. Net profit attributable to shareholders was ₹15.22 crore, and consolidated profit before tax was negative at ₹10.75 crore. Standalone total income was ₹437.26 crore and standalone net profit ₹13.27 crore.
- Earnings
- Pharma CDMO